Report Detail
Global Clinical Trials Outsourcing Market Growth (Status and Outlook) 2022-2028
- RnM4486113 |
- 24 August, 2022 |
- Global |
- 122 Pages |
- LPI(LP Information) |
- Service & Software
The global market for Clinical Trials Outsourcing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Clinical Trials Outsourcing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Clinical Trials Outsourcing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Clinical Trials Outsourcing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Clinical Trials Outsourcing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Clinical Trials Outsourcing players cover Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development and Syneos Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Clinical Trials Outsourcing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Clinical Trials Outsourcing market, with both quantitative and qualitative data, to help readers understand how the Clinical Trials Outsourcing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Clinical Trials Outsourcing market and forecasts the market size by Clinical Trial Phase (Phase I, Phase II and Phase III), by Application (Cancer, CVDs, Infectious Diseases and Musculoskeletal Diseases), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by clinical trial phase
Phase I
Phase II
Phase III
Phase IV
Segmentation by application
Cancer
CVDs
Infectious Diseases
Musculoskeletal Diseases
Nervous System Disorders
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Charles River Laboratories
IQVIA
ICON PLC
Labcorp Drug Development
Syneos Health
Thermo Fisher Scientific
Wuxi AppTec
Parexel
Advanced Clinical
BioAnalytix
Curia Global
CMED
Cromos Pharma
Criterium
KCR S.A.
Medpace
Medelis
OCT Group
ProTrials Research
PROMETRIKA
Quality Data Service
QPS
Sofpromed
Veristat
Worldwide Clinical Trials
Chapter Introduction
Chapter 1: Scope of Clinical Trials Outsourcing, Research Methodology, etc.
Chapter 2: Executive Summary, global Clinical Trials Outsourcing market size and CAGR, Clinical Trials Outsourcing market size by region, by clinical trial phase, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Clinical Trials Outsourcing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Clinical Trials Outsourcing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by clinical trial phase, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Clinical Trials Outsourcing market size forecast by region, by country, by clinical trial phase, and application
Chapter 13: Comprehensive company profiles of the leading players, including Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development, Syneos Health, Thermo Fisher Scientific, Wuxi AppTec, Parexel and Advanced Clinical, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Clinical Trials Outsourcing Market Size 2017-2028
- 2.1.2 Clinical Trials Outsourcing Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Clinical Trials Outsourcing Segment by Clinical Trial Phase
- 2.2.1 Phase I
- 2.2.2 Phase II
- 2.2.3 Phase III
- 2.2.4 Phase IV
- 2.3 Clinical Trials Outsourcing Market Size by Clinical Trial Phase
- 2.3.1 Clinical Trials Outsourcing Market Size CAGR by Clinical Trial Phase (2017 VS 2022 VS 2028)
- 2.3.2 Global Clinical Trials Outsourcing Market Size Market Share by Clinical Trial Phase (2017-2022)
- 2.4 Clinical Trials Outsourcing Segment by Application
- 2.4.1 Cancer
- 2.4.2 CVDs
- 2.4.3 Infectious Diseases
- 2.4.4 Musculoskeletal Diseases
- 2.4.5 Nervous System Disorders
- 2.4.6 Others
- 2.5 Clinical Trials Outsourcing Market Size by Application
- 2.5.1 Clinical Trials Outsourcing Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Clinical Trials Outsourcing Market Size Market Share by Application (2017-2022)
3 Clinical Trials Outsourcing Market Size by Player
- 3.1 Clinical Trials Outsourcing Market Size Market Share by Players
- 3.1.1 Global Clinical Trials Outsourcing Revenue by Players (2020-2022)
- 3.1.2 Global Clinical Trials Outsourcing Revenue Market Share by Players (2020-2022)
- 3.2 Global Clinical Trials Outsourcing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Clinical Trials Outsourcing by Regions
- 4.1 Clinical Trials Outsourcing Market Size by Regions (2017-2022)
- 4.2 Americas Clinical Trials Outsourcing Market Size Growth (2017-2022)
- 4.3 APAC Clinical Trials Outsourcing Market Size Growth (2017-2022)
- 4.4 Europe Clinical Trials Outsourcing Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Clinical Trials Outsourcing Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Clinical Trials Outsourcing Market Size by Country (2017-2022)
- 5.2 Americas Clinical Trials Outsourcing Market Size by Clinical Trial Phase (2017-2022)
- 5.3 Americas Clinical Trials Outsourcing Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Clinical Trials Outsourcing Market Size by Region (2017-2022)
- 6.2 APAC Clinical Trials Outsourcing Market Size by Clinical Trial Phase (2017-2022)
- 6.3 APAC Clinical Trials Outsourcing Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Clinical Trials Outsourcing by Country (2017-2022)
- 7.2 Europe Clinical Trials Outsourcing Market Size by Clinical Trial Phase (2017-2022)
- 7.3 Europe Clinical Trials Outsourcing Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Clinical Trials Outsourcing by Region (2017-2022)
- 8.2 Middle East & Africa Clinical Trials Outsourcing Market Size by Clinical Trial Phase (2017-2022)
- 8.3 Middle East & Africa Clinical Trials Outsourcing Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Clinical Trials Outsourcing Market Forecast
- 10.1 Global Clinical Trials Outsourcing Forecast by Regions (2023-2028)
- 10.1.1 Global Clinical Trials Outsourcing Forecast by Regions (2023-2028)
- 10.1.2 Americas Clinical Trials Outsourcing Forecast
- 10.1.3 APAC Clinical Trials Outsourcing Forecast
- 10.1.4 Europe Clinical Trials Outsourcing Forecast
- 10.1.5 Middle East & Africa Clinical Trials Outsourcing Forecast
- 10.2 Americas Clinical Trials Outsourcing Forecast by Country (2023-2028)
- 10.2.1 United States Clinical Trials Outsourcing Market Forecast
- 10.2.2 Canada Clinical Trials Outsourcing Market Forecast
- 10.2.3 Mexico Clinical Trials Outsourcing Market Forecast
- 10.2.4 Brazil Clinical Trials Outsourcing Market Forecast
- 10.3 APAC Clinical Trials Outsourcing Forecast by Region (2023-2028)
- 10.3.1 China Clinical Trials Outsourcing Market Forecast
- 10.3.2 Japan Clinical Trials Outsourcing Market Forecast
- 10.3.3 Korea Clinical Trials Outsourcing Market Forecast
- 10.3.4 Southeast Asia Clinical Trials Outsourcing Market Forecast
- 10.3.5 India Clinical Trials Outsourcing Market Forecast
- 10.3.6 Australia Clinical Trials Outsourcing Market Forecast
- 10.4 Europe Clinical Trials Outsourcing Forecast by Country (2023-2028)
- 10.4.1 Germany Clinical Trials Outsourcing Market Forecast
- 10.4.2 France Clinical Trials Outsourcing Market Forecast
- 10.4.3 UK Clinical Trials Outsourcing Market Forecast
- 10.4.4 Italy Clinical Trials Outsourcing Market Forecast
- 10.4.5 Russia Clinical Trials Outsourcing Market Forecast
- 10.5 Middle East & Africa Clinical Trials Outsourcing Forecast by Region (2023-2028)
- 10.5.1 Egypt Clinical Trials Outsourcing Market Forecast
- 10.5.2 South Africa Clinical Trials Outsourcing Market Forecast
- 10.5.3 Israel Clinical Trials Outsourcing Market Forecast
- 10.5.4 Turkey Clinical Trials Outsourcing Market Forecast
- 10.5.5 GCC Countries Clinical Trials Outsourcing Market Forecast
- 10.6 Global Clinical Trials Outsourcing Forecast by Clinical Trial Phase (2023-2028)
- 10.7 Global Clinical Trials Outsourcing Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Charles River Laboratories
- 11.1.1 Charles River Laboratories Company Information
- 11.1.2 Charles River Laboratories Clinical Trials Outsourcing Product Offered
- 11.1.3 Charles River Laboratories Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Charles River Laboratories Main Business Overview
- 11.1.5 Charles River Laboratories Latest Developments
- 11.2 IQVIA
- 11.2.1 IQVIA Company Information
- 11.2.2 IQVIA Clinical Trials Outsourcing Product Offered
- 11.2.3 IQVIA Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 IQVIA Main Business Overview
- 11.2.5 IQVIA Latest Developments
- 11.3 ICON PLC
- 11.3.1 ICON PLC Company Information
- 11.3.2 ICON PLC Clinical Trials Outsourcing Product Offered
- 11.3.3 ICON PLC Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 ICON PLC Main Business Overview
- 11.3.5 ICON PLC Latest Developments
- 11.4 Labcorp Drug Development
- 11.4.1 Labcorp Drug Development Company Information
- 11.4.2 Labcorp Drug Development Clinical Trials Outsourcing Product Offered
- 11.4.3 Labcorp Drug Development Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Labcorp Drug Development Main Business Overview
- 11.4.5 Labcorp Drug Development Latest Developments
- 11.5 Syneos Health
- 11.5.1 Syneos Health Company Information
- 11.5.2 Syneos Health Clinical Trials Outsourcing Product Offered
- 11.5.3 Syneos Health Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Syneos Health Main Business Overview
- 11.5.5 Syneos Health Latest Developments
- 11.6 Thermo Fisher Scientific
- 11.6.1 Thermo Fisher Scientific Company Information
- 11.6.2 Thermo Fisher Scientific Clinical Trials Outsourcing Product Offered
- 11.6.3 Thermo Fisher Scientific Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Thermo Fisher Scientific Main Business Overview
- 11.6.5 Thermo Fisher Scientific Latest Developments
- 11.7 Wuxi AppTec
- 11.7.1 Wuxi AppTec Company Information
- 11.7.2 Wuxi AppTec Clinical Trials Outsourcing Product Offered
- 11.7.3 Wuxi AppTec Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Wuxi AppTec Main Business Overview
- 11.7.5 Wuxi AppTec Latest Developments
- 11.8 Parexel
- 11.8.1 Parexel Company Information
- 11.8.2 Parexel Clinical Trials Outsourcing Product Offered
- 11.8.3 Parexel Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Parexel Main Business Overview
- 11.8.5 Parexel Latest Developments
- 11.9 Advanced Clinical
- 11.9.1 Advanced Clinical Company Information
- 11.9.2 Advanced Clinical Clinical Trials Outsourcing Product Offered
- 11.9.3 Advanced Clinical Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Advanced Clinical Main Business Overview
- 11.9.5 Advanced Clinical Latest Developments
- 11.10 BioAnalytix
- 11.10.1 BioAnalytix Company Information
- 11.10.2 BioAnalytix Clinical Trials Outsourcing Product Offered
- 11.10.3 BioAnalytix Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 BioAnalytix Main Business Overview
- 11.10.5 BioAnalytix Latest Developments
- 11.11 Curia Global
- 11.11.1 Curia Global Company Information
- 11.11.2 Curia Global Clinical Trials Outsourcing Product Offered
- 11.11.3 Curia Global Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Curia Global Main Business Overview
- 11.11.5 Curia Global Latest Developments
- 11.12 CMED
- 11.12.1 CMED Company Information
- 11.12.2 CMED Clinical Trials Outsourcing Product Offered
- 11.12.3 CMED Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 CMED Main Business Overview
- 11.12.5 CMED Latest Developments
- 11.13 Cromos Pharma
- 11.13.1 Cromos Pharma Company Information
- 11.13.2 Cromos Pharma Clinical Trials Outsourcing Product Offered
- 11.13.3 Cromos Pharma Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Cromos Pharma Main Business Overview
- 11.13.5 Cromos Pharma Latest Developments
- 11.14 Criterium
- 11.14.1 Criterium Company Information
- 11.14.2 Criterium Clinical Trials Outsourcing Product Offered
- 11.14.3 Criterium Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Criterium Main Business Overview
- 11.14.5 Criterium Latest Developments
- 11.15 KCR S.A.
- 11.15.1 KCR S.A. Company Information
- 11.15.2 KCR S.A. Clinical Trials Outsourcing Product Offered
- 11.15.3 KCR S.A. Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 KCR S.A. Main Business Overview
- 11.15.5 KCR S.A. Latest Developments
- 11.16 Medpace
- 11.16.1 Medpace Company Information
- 11.16.2 Medpace Clinical Trials Outsourcing Product Offered
- 11.16.3 Medpace Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Medpace Main Business Overview
- 11.16.5 Medpace Latest Developments
- 11.17 Medelis
- 11.17.1 Medelis Company Information
- 11.17.2 Medelis Clinical Trials Outsourcing Product Offered
- 11.17.3 Medelis Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Medelis Main Business Overview
- 11.17.5 Medelis Latest Developments
- 11.18 OCT Group
- 11.18.1 OCT Group Company Information
- 11.18.2 OCT Group Clinical Trials Outsourcing Product Offered
- 11.18.3 OCT Group Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 OCT Group Main Business Overview
- 11.18.5 OCT Group Latest Developments
- 11.19 ProTrials Research
- 11.19.1 ProTrials Research Company Information
- 11.19.2 ProTrials Research Clinical Trials Outsourcing Product Offered
- 11.19.3 ProTrials Research Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 ProTrials Research Main Business Overview
- 11.19.5 ProTrials Research Latest Developments
- 11.20 PROMETRIKA
- 11.20.1 PROMETRIKA Company Information
- 11.20.2 PROMETRIKA Clinical Trials Outsourcing Product Offered
- 11.20.3 PROMETRIKA Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 PROMETRIKA Main Business Overview
- 11.20.5 PROMETRIKA Latest Developments
- 11.21 Quality Data Service
- 11.21.1 Quality Data Service Company Information
- 11.21.2 Quality Data Service Clinical Trials Outsourcing Product Offered
- 11.21.3 Quality Data Service Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.21.4 Quality Data Service Main Business Overview
- 11.21.5 Quality Data Service Latest Developments
- 11.22 QPS
- 11.22.1 QPS Company Information
- 11.22.2 QPS Clinical Trials Outsourcing Product Offered
- 11.22.3 QPS Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.22.4 QPS Main Business Overview
- 11.22.5 QPS Latest Developments
- 11.23 Sofpromed
- 11.23.1 Sofpromed Company Information
- 11.23.2 Sofpromed Clinical Trials Outsourcing Product Offered
- 11.23.3 Sofpromed Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.23.4 Sofpromed Main Business Overview
- 11.23.5 Sofpromed Latest Developments
- 11.24 Veristat
- 11.24.1 Veristat Company Information
- 11.24.2 Veristat Clinical Trials Outsourcing Product Offered
- 11.24.3 Veristat Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.24.4 Veristat Main Business Overview
- 11.24.5 Veristat Latest Developments
- 11.25 Worldwide Clinical Trials
- 11.25.1 Worldwide Clinical Trials Company Information
- 11.25.2 Worldwide Clinical Trials Clinical Trials Outsourcing Product Offered
- 11.25.3 Worldwide Clinical Trials Clinical Trials Outsourcing Revenue, Gross Margin and Market Share (2020-2022)
- 11.25.4 Worldwide Clinical Trials Main Business Overview
- 11.25.5 Worldwide Clinical Trials Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Clinical Trials Outsourcing. Industry analysis & Market Report on Clinical Trials Outsourcing is a syndicated market report, published as Global Clinical Trials Outsourcing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Clinical Trials Outsourcing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
